ArticleBMC plant biology2026
Integrated metabolomics and transcriptomics investigate the bulb-specific biosynthesis of medicinal steroidal alkaloids in Fritillaria taipaiensis.
Article in BMC plant biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundFritillaria taipaiensis is a commercially important medicinal herb, the bulbs of which are a valued source of steroidal alkaloids with potent antitussive and expectorant properties. However, the mechanisms underlying the tissue-specific biosynthesis of these bioactive compounds remain poorly understood, limiting strategies for their enhanced production.
resultsThis study, we integrated UPLC-MS/MS-based metabolomics with multi-tissue transcriptomics to elucidate the steroidal alkaloid biosynthetic pathway in F. taipaiensis. Comparative metabolomic profiling revealed distinct tissue-specific accumulation patterns, with bulbs serving as the primary site for therapeutically relevant steroidal alkaloids such as peimisine, edpetiline, and delafrine. Transcriptomic analysis unveiled metabolic compartmentalization, characterized by the bulb-specific upregulation of mevalonate (MVA) pathway genes, contrasting with leaf-predominant expression of methylerythritol phosphate (MEP) pathway components. This indicates a tissue-specific partitioning of precursor supply. Of note, we identified bulb-specific isoforms FrtSSR1 (encoding a Δ²⁴(²⁵)-reductase) and FrtSMO1-1 (encoding a C-4 demethylase), which were highly expressed and are proposed to pivotal roles in redirecting metabolic flux toward cholesterol biosynthesis. Furthermore, the coordinated induction of cytochrome P450 enzymes in bulbs suggests their involvement in mediating structural diversification of the steroidal skeleton.
conclusionsOur findings systematically unravel the molecular basis of bulb-specific steroidal alkaloid accumulation, highlighting pathway specialization, enzyme subfunctionalization, and CYP450-mediated modification. This study provides a genetic foundation and key candidate genes for future metabolic engineering and molecular breeding strategies aimed at improving the yield of high-value steroidal alkaloids in Fritillaria species.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.